Radiopharmaceutical Validation for Clinical Use

Radiopharmaceutical Validation for Clinical Use

Radiopharmaceuticals are reemerging as attractive anticancer agents, but there are no universally adopted guidelines or standardized procedures for evaluating agent validity before early-phase trial implementation. To validate a radiopharmaceutical, it is desirous for the radiopharmaceutical to be s...

Full description

Bibliographic Details
Main Authors: Charles A. Kunos, Rodney Howells, Aman Chauhan, Zin W. Myint, Mark E. Bernard, Riham El Khouli, Jacek Capala
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
radiopharmaceutical
preclinical
validation
nuclear medicine
radiation oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.630827/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.630827/full

Similar Items